Catalyst Event
Alteogen Inc (196170) · Other
From KRX Bio Technology Transfer Index (KBIOTT)
3/23/2026, 12:00:00 AM
Alteogen announced on March 23, 2026, that it will present positive experimental results for a subcutaneous (SC) formulation of Antibody-Drug Conjugate (ADC) therapies at the 'World ADC Asia 2026' conference; medium impact expected as clinical data presentations are significant catalysts for biotech stocks, scheduled.
Korean Translation
2026년 3월 23일, 항체-약물 접합체(ADC) 치료제의 피하주사(SC) 제형에 대한 긍정적인 실험 결과를 2026년 6월 'World ADC Asia 2026' 학회에서 발표할 것이라고 밝힘; 임상 데이터 발표는 기업 가치에 긍정적인 영향을 미치므로 중간 수준의 영향이 예상됨, 예정됨.
Related Recent Events
LigaChem Biosciences Inc (141080) · Other
Presentation of preclinical results for two next-generation BCMA ADC pipeline candidates at the American Association for Cancer Research (AACR) 2026 annual meeting scheduled
4/17/2026, 12:00:00 AM
Hanmi Pharm Co Ltd (128940) · Other
The 16th annual general shareholders' meeting is scheduled for March 31, 2026. Key agenda items include the appointment of directors, with potential for a proxy fight amid a renewed management dispute between major shareholders and current management. High impact is estimated as management disputes often lead to significant price volatility scheduled
3/31/2026, 12:00:00 AM
LigaChem Biosciences Inc (141080) · Other
The 20th Annual General Meeting of Shareholders including approval of financial statements and appointment of a new director scheduled
3/31/2026, 12:00:00 AM
OliX Pharmaceuticals Inc (226950) · Other
Announcement of positive preclinical results for obesity treatment OLX501A showing 84% ALK7 gene suppression in primates and plans to accelerate development expected. High efficacy in primate studies is estimated to result in a price impact of over 5%, expected.
3/24/2026, 12:00:00 AM
Hanmi Pharm Co Ltd (128940) · Other
Approval from the Ministry of Food and Drug Safety to add 'back pain' as an indication for the NSAID combination drug 'Naxozol' is expected on March 24, 2026. Low impact is estimated as this is an incremental update to an existing product scheduled
3/24/2026, 12:00:00 AM
GC Cell Corporation (144510) · Other
The 15th Annual General Meeting of Shareholders was held on March 24, 2026, where the approval of financial statements and the re-appointment of an internal director were resolved.
3/24/2026, 12:00:00 AM